User:Apolena Zounarová/Sandbox 1
From Proteopedia
< User:Apolena Zounarová(Difference between revisions)
Line 9: | Line 9: | ||
=== Proteolytic Events During Notch1 Secretion and Signal Transduction === | === Proteolytic Events During Notch1 Secretion and Signal Transduction === | ||
====Furin-type Convertase Cleavage==== | ====Furin-type Convertase Cleavage==== | ||
- | Notch1 is posttranslationally modified by a proteolytic cleavage at S1 sites and reaches the plasma membrane as a heterodimer. Non-cleaved Notch1 is autoinhibited. Furin-type convertase is responsible for this process and cleaves Notch1 in at least two places: after R1633 and after R1664 <ref name=" | + | Notch1 is posttranslationally modified by a proteolytic cleavage at S1 sites and reaches the plasma membrane as a heterodimer. Non-cleaved Notch1 is autoinhibited. Furin-type convertase is responsible for this process and cleaves Notch1 in at least two places: after R1633 and after R1664 <ref name="gordon">DOI 10.1371/JOURNAL.PONE.0006613</ref>. Both residues are located in a loop exposed into the cytosol and lie approximately 100 and 70 amino acids external from the transmembrane region, respectively <ref name="gordon"/><ref="uniprot">DOI 10.1093/NAR/GKAA1100</ref>. |
====Additional Cleavages in Response to Receptor Activation==== | ====Additional Cleavages in Response to Receptor Activation==== | ||
Line 20: | Line 20: | ||
== T-cell Acute Lymphoblastic Leukaemia == | == T-cell Acute Lymphoblastic Leukaemia == | ||
- | T-cell-acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic tumor that predominantly affects children and adolescents. T-ALL is more prevalent in males. T-ALL is manifested by malignant differentiation of the multipotent precursor cells of the lymphoid lineage which lost their ability to mature and became the leukemic blasts infiltrating bone marrow. T-ALL overall has a poor prognosis, 5-year relapse-free survival rate is over 75 % in children and 50 % in adults <ref>DOI 10.1016/S0140-6736(08)60457-2</ref>. | + | T-cell-acute lymphoblastic leukemia (T-ALL) is an aggressive hematologic tumor that predominantly affects children and adolescents. T-ALL is more prevalent in males. T-ALL is manifested by malignant differentiation of the multipotent precursor cells of the lymphoid lineage which lost their ability to mature and became the leukemic blasts infiltrating bone marrow. T-ALL overall has a poor prognosis, 5-year relapse-free survival rate is over 75 % in children and 50 % in adults <ref name="pui">DOI 10.1016/S0140-6736(08)60457-2</ref>. |
- | The importance of Notch1 mutations in T-ALL has been shown by Weng and colleagues <ref>DOI 10.1126/science.1102160</ref>. 44 % of Notch-dependent T-ALL cell lines harboured gain-of-function mutations in the heterodimerization domain. Moreover, about 40 % of these cases were accompanied by mutations in the intracellular PEST domain of Notch1 which is important for the signal termination <ref>DOI 10.1093/genetics/135.3.765</ref>. Weng and colleagues proposed a model of synergy in which mutations in the heterodimerization domain increase the production of NICD by γ-secretase cleavage while mutations in intracellular PEST domain increases its half-life. Cell lines with mutations in the heterodimerization domain are sensitive to γ-secretase inhibitors and exhibit G0/G1 cell cycle arrest opposed to PEST domain mutants which are unaffected by the inhibitor <ref | + | The importance of Notch1 mutations in T-ALL has been shown by Weng and colleagues <ref name="weng">DOI 10.1126/science.1102160</ref>. 44 % of Notch-dependent T-ALL cell lines harboured gain-of-function mutations in the heterodimerization domain. Moreover, about 40 % of these cases were accompanied by mutations in the intracellular PEST domain of Notch1 which is important for the signal termination <ref name="sundaram">DOI 10.1093/genetics/135.3.765</ref>. Weng and colleagues proposed a model of synergy in which mutations in the heterodimerization domain increase the production of NICD by γ-secretase cleavage while mutations in intracellular PEST domain increases its half-life. Cell lines with mutations in the heterodimerization domain are sensitive to γ-secretase inhibitors and exhibit G0/G1 cell cycle arrest opposed to PEST domain mutants which are unaffected by the inhibitor <ref name="weng"/>. Common mutations found in human T-ALL and acting in γ-secretase-dependent manner are L1575P, L1594P, and L1601P <ref name="malecki">DOI 10.1128/MCB.01655-05</ref><ref name="weng"/>. |
Current revision
Notch1 Heterodimerization Domain in T-cell Acute Lymphoblastic Leukaemia
|
References
- ↑ Aster JC, Pear WS, Blacklow SC. Notch signaling in leukemia. Annu Rev Pathol. 2008;3:587-613. doi:, 10.1146/annurev.pathmechdis.3.121806.154300. PMID:18039126 doi:http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.154300
- ↑ 2.0 2.1 Gordon WR, Vardar-Ulu D, L'Heureux S, Ashworth T, Malecki MJ, Sanchez-Irizarry C, McArthur DG, Histen G, Mitchell JL, Aster JC, Blacklow SC. Effects of S1 cleavage on the structure, surface export, and signaling activity of human Notch1 and Notch2. PLoS One. 2009 Aug 24;4(8):e6613. PMID:19701457 doi:10.1371/journal.pone.0006613
- ↑ 3.0 3.1 3.2 Brou C, Logeat F, Gupta N, Bessia C, LeBail O, Doedens JR, Cumano A, Roux P, Black RA, Israel A. A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell. 2000 Feb;5(2):207-16. doi: 10.1016/s1097-2765(00)80417-7. PMID:10882063 doi:http://dx.doi.org/10.1016/s1097-2765(00)80417-7
- ↑ Mumm JS, Schroeter EH, Saxena MT, Griesemer A, Tian X, Pan DJ, Ray WJ, Kopan R. A ligand-induced extracellular cleavage regulates gamma-secretase-like proteolytic activation of Notch1. Mol Cell. 2000 Feb;5(2):197-206. doi: 10.1016/s1097-2765(00)80416-5. PMID:10882062 doi:http://dx.doi.org/10.1016/s1097-2765(00)80416-5
- ↑ Cite error: Invalid
<ref>
tag; no text was provided for refs nameduniprot
- ↑ Nichols JT, Miyamoto A, Olsen SL, D'Souza B, Yao C, Weinmaster G. DSL ligand endocytosis physically dissociates Notch1 heterodimers before activating proteolysis can occur. J Cell Biol. 2007 Feb 12;176(4):445-58. doi: 10.1083/jcb.200609014. PMID:17296795 doi:http://dx.doi.org/10.1083/jcb.200609014
- ↑ 7.0 7.1 De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, Schroeter EH, Schrijvers V, Wolfe MS, Ray WJ, Goate A, Kopan R. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature. 1999 Apr 8;398(6727):518-22. doi: 10.1038/19083. PMID:10206645 doi:http://dx.doi.org/10.1038/19083
- ↑ Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature. 1998 May 28;393(6683):382-6. doi: 10.1038/30756. PMID:9620803 doi:http://dx.doi.org/10.1038/30756
- ↑ Sanchez-Irizarry C, Carpenter AC, Weng AP, Pear WS, Aster JC, Blacklow SC. Notch subunit heterodimerization and prevention of ligand-independent proteolytic activation depend, respectively, on a novel domain and the LNR repeats. Mol Cell Biol. 2004 Nov;24(21):9265-73. doi: 10.1128/MCB.24.21.9265-9273.2004. PMID:15485896 doi:http://dx.doi.org/10.1128/MCB.24.21.9265-9273.2004
- ↑ Kopan R, Schroeter EH, Weintraub H, Nye JS. Signal transduction by activated mNotch: importance of proteolytic processing and its regulation by the extracellular domain. Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1683-8. doi: 10.1073/pnas.93.4.1683. PMID:8643690 doi:http://dx.doi.org/10.1073/pnas.93.4.1683
- ↑ Pui CH, Robison LL, Look AT. Acute lymphoblastic leukaemia. Lancet. 2008 Mar 22;371(9617):1030-43. doi: 10.1016/S0140-6736(08)60457-2. PMID:18358930 doi:http://dx.doi.org/10.1016/S0140-6736(08)60457-2
- ↑ 12.0 12.1 12.2 Weng AP, Ferrando AA, Lee W, Morris JP 4th, Silverman LB, Sanchez-Irizarry C, Blacklow SC, Look AT, Aster JC. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science. 2004 Oct 8;306(5694):269-71. doi: 10.1126/science.1102160. PMID:15472075 doi:http://dx.doi.org/10.1126/science.1102160
- ↑ doi: https://dx.doi.org/10.1093/genetics/135.3.765
- ↑ Malecki MJ, Sanchez-Irizarry C, Mitchell JL, Histen G, Xu ML, Aster JC, Blacklow SC. Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes. Mol Cell Biol. 2006 Jun;26(12):4642-51. doi: 10.1128/MCB.01655-05. PMID:16738328 doi:http://dx.doi.org/10.1128/MCB.01655-05
- ↑ Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
- ↑ Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644